2BBBullish & Bearish
Health Care

Caribou Biosciences, Inc. (CRBU) Stock Score & Signals

Caribou Biosciences, Inc. (CRBU) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 15 out of 100.

About Caribou Biosciences, Inc.

Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases.

2BB score and signals

Caribou Biosciences, Inc.’s current 2BB score is 15 out of 100, built from the signal categories below.

SignalScoreReading
Activity3Very Low
Momentum32Weakening
Financial strength9Very Weak
Company Presence55Normal
Risk49Moderate (provisional)

Company facts

HeadquartersBerkeley, California, United States
FoundedJan 1, 2011
Employees97
52-week range$0.44 – $3.53

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-03-01—-0.1955—$2.96M
2026-11-05-0.25-0.2756$1.61M$1.65M
2026-08-13—-0.3232—$2.32M
2026-05-07-0.26-0.3242$2.40M$2.29M